Tag: Liver Disease: Misc.
FDA Reports Rare Cases of Liver Injury, Failure With Hep C Therapies
Worsening liver functioning, liver failure reported among patients contraindicated for HCV therapies
Common Therapy for Obstetric Cholestasis Found Ineffective
Treatment with ursodeoxycholic acid versus placebo yielded no significant difference in outcome
Superior Outcomes Seen for Living Donor Liver Transplant
Living donor versus deceased donor liver transplant also yields less resource utilization
T2DM Is Risk Factor for Liver Fibrosis Progression in NAFLD
In multivariate analysis, age, albumin concentration, T2DM independently tied to progression
Digestive Disease Week, May 18-21
Digestive Disease Week 2019 The annual Digestive Disease Week, sponsored by the American Association for the Study of Liver Diseases, American Gastroenterological Association,...
Adverse Liver Outcomes Up With Diagnosis of NAFLD/NASH
Baseline diagnosis of diabetes independent predictor of advanced liver disease diagnosis
U.S. Prevalence of Alcoholic Fatty Liver Disease Stable at 4.7 Percent
But prevalence of AFLD with stage 2 or greater fibrosis, AFLD with stage 3 or greater fibrosis increased
Fibrosis, Steatosis of the Liver Observed in Some Young Adults
Within Avon Longitudinal Study cohort, 2.4 percent of young adults had fibrosis; 20.8 percent had steatosis
Nonalcoholic Fatty Liver Disease Burden Up Among HIV-Infected
NAFLD becoming increasingly important cause of liver disease, liver mortality
Stillbirth Risk Up With High Serum Bile Acids in Pregnancy
Higher risk of stillbirth with serum bile acids ≥100 µmol/L in intrahepatic cholestasis of pregnancy
